Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
158.71 x 100 171.31 x 100
Post-market by (Cboe BZX)
161.91 -2.74 (-1.66%) 04/01/25 [NYSE]
158.71 x 100 171.31 x 100
Post-market 161.91 unch (unch) 16:40 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
161.39
Day High
165.72
Open 163.92
Previous Close 164.65 164.65
Volume 2,734,900 2,734,900
Avg Vol 2,475,725 2,475,725
Stochastic %K 56.01% 56.01%
Weighted Alpha -6.12 -6.12
5-Day Change +0.61 (+0.38%) +0.61 (+0.38%)
52-Week Range 144.80 - 200.33 144.80 - 200.33
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 73,728,952
  • Shares Outstanding, K 447,792
  • Annual Sales, $ 9,256 M
  • Annual Income, $ 2,486 M
  • EBIT $ 3,274 M
  • EBITDA $ 3,771 M
  • 60-Month Beta 0.94
  • Price/Sales 7.89
  • Price/Cash Flow 23.07
  • Price/Book 15.43

Options Overview Details

View History
  • Implied Volatility 29.26% ( -0.61%)
  • Historical Volatility 24.69%
  • IV Percentile 73%
  • IV Rank 35.81%
  • IV High 46.29% on 08/05/24
  • IV Low 19.76% on 08/16/24
  • Put/Call Vol Ratio 0.50
  • Today's Volume 382
  • Volume Avg (30-Day) 1,201
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 38,907
  • Open Int (30-Day) 40,584

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.40
  • Number of Estimates 10
  • High Estimate 1.44
  • Low Estimate 1.37
  • Prior Year 1.38
  • Growth Rate Est. (year over year) +1.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
158.30 +2.28%
on 03/14/25
Period Open: 167.24
177.00 -8.53%
on 03/10/25
-5.33 (-3.19%)
since 02/28/25
3-Month
154.32 +4.92%
on 02/18/25
Period Open: 162.93
177.40 -8.73%
on 02/06/25
-1.02 (-0.63%)
since 12/31/24
52-Week
144.80 +11.82%
on 04/22/24
Period Open: 167.02
200.33 -19.18%
on 09/19/24
-5.11 (-3.06%)
since 04/01/24

Most Recent Stories

More News
Zoetis' Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.

Shares in animal pharmaceutical company Zoetis (NYSE: ZTS) have been under a cloud since the release of the company's fourth-quarter earnings report in mid-February. The Q4 numbers were fine, but the company's...

JPM : 243.66 (-0.67%)
ZTS : 161.91 (-1.66%)
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

SUPN : 31.68 (-3.27%)
OGN : 14.13 (-5.10%)
ZTS : 161.91 (-1.66%)
PFE : 24.54 (-3.16%)
BMY : 59.55 (-2.36%)
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

RPRX : 31.17 (+0.13%)
COLL : 29.39 (-1.54%)
SUPN : 31.68 (-3.27%)
OGN : 14.13 (-5.10%)
ZTS : 161.91 (-1.66%)
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

ELAN : 10.35 (-1.43%)
JAZZ : 124.99 (+0.68%)
VTRS : 8.60 (-1.26%)
ZTS : 161.91 (-1.66%)
ANIP : 68.02 (+1.60%)
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

SUPN : 31.68 (-3.27%)
JNJ : 153.25 (-7.59%)
ZTS : 161.91 (-1.66%)
LLY : 805.23 (-2.50%)
PFE : 24.54 (-3.16%)
How Is Zoetis’ Stock Performance Compared to Other Pet Care Stocks?

Zoetis has notably lagged behind other pet care stocks over the past year, yet analysts remain strongly bullish on the stock’s prospects.

PAWZ : 52.35 (+0.20%)
MRK : 87.12 (-2.94%)
ZTS : 161.91 (-1.66%)
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

CORT : 91.93 (-19.51%)
RPRX : 31.17 (+0.13%)
SUPN : 31.68 (-3.27%)
OGN : 14.13 (-5.10%)
ZTS : 161.91 (-1.66%)
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

CORT : 91.93 (-19.51%)
SUPN : 31.68 (-3.27%)
MRK : 87.12 (-2.94%)
ZTS : 161.91 (-1.66%)
BMY : 59.55 (-2.36%)
Zoetis (ZTS): Buy, Sell, or Hold Post Q4 Earnings?

Zoetis (ZTS): Buy, Sell, or Hold Post Q4 Earnings?

ZTS : 161.91 (-1.66%)
Rule Breaker Investing: Pet Perks, Vol. 2

Little things can make a big difference.

NFLX : 928.38 (-0.45%)
CPRT : 57.21 (+1.10%)
AAPL : 223.19 (+0.48%)
TSLA : 268.46 (+3.59%)
SPOT : 551.73 (+0.31%)
CROX : 109.14 (+2.77%)
ZTS : 161.91 (-1.66%)
AXON : 541.20 (+2.90%)
AMZN : 192.17 (+1.00%)
WMT : 88.83 (+1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 168.95
2nd Resistance Point 167.34
1st Resistance Point 164.62
Last Price 161.91
1st Support Level 160.29
2nd Support Level 158.68
3rd Support Level 155.96

See More

52-Week High 200.33
Fibonacci 61.8% 179.12
Fibonacci 50% 172.57
Fibonacci 38.2% 166.01
Last Price 161.91
52-Week Low 144.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies